Zurcher Kantonalbank Zurich Cantonalbank Purchases 6,841 Shares of Solventum Co. (NYSE:SOLV)

Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Solventum Co. (NYSE:SOLV - Free Report) by 6.5% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 111,757 shares of the company's stock after buying an additional 6,841 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank owned 0.06% of Solventum worth $7,383,000 as of its most recent SEC filing.

Other institutional investors have also bought and sold shares of the company. Modus Advisors LLC purchased a new stake in Solventum in the 4th quarter worth $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum in the 4th quarter worth $26,000. True Wealth Design LLC increased its stake in Solventum by 23,550.0% in the 3rd quarter. True Wealth Design LLC now owns 473 shares of the company's stock worth $33,000 after buying an additional 471 shares in the last quarter. Crews Bank & Trust purchased a new stake in Solventum in the 4th quarter worth $32,000. Finally, Prospera Private Wealth LLC purchased a new stake in Solventum in the 3rd quarter worth $35,000.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on SOLV. Bank of America increased their price target on Solventum from $80.00 to $85.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. Mizuho raised their price objective on Solventum from $70.00 to $82.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. The Goldman Sachs Group raised their price objective on Solventum from $63.00 to $71.00 and gave the company a "sell" rating in a research report on Monday, March 3rd. Wells Fargo & Company raised their price objective on Solventum from $73.00 to $75.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Finally, Morgan Stanley raised their price objective on Solventum from $73.00 to $80.00 and gave the company an "equal weight" rating in a research report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $79.86.

Remove Ads

Solventum Trading Up 1.2 %

SOLV traded up $0.88 on Monday, hitting $75.04. The company had a trading volume of 852,669 shares, compared to its average volume of 1,431,733. The company has a market cap of $12.98 billion and a PE ratio of 27.29. Solventum Co. has a 12-month low of $47.16 and a 12-month high of $85.92. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The business's fifty day simple moving average is $74.52 and its 200 day simple moving average is $71.22.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.